Biopharmaceutical company GlobeImmune files for a $69 million IPO

GlobeImmune, a developer of therapeutic drugs for cancer and infectious diseases, filed on Tuesday with the SEC to raise up to $69 million in an initial public offering. The company has four product candidates in five ongoing clinical trials.The Louisville, CO-based company has two strategic collaborations, one with Celgene for all oncology related product candidates and the other with Gilead Sciences...

Marathon Petroleum's MPLX LP files for a $365 million IPO

MPLX LP, a LP formed by Marathon Petroleum Corporation to own and operate pipelines and other midstream assets in the Midwest and Gulf Coast regions, filed on Tuesday with the SEC to raise up to $365 million in an initial public offering. Marathon Petroleum trades on the NYSE under the ticker MPC.The Findlay, OH-based company, which was founded in 2012 and booked $418 million in revenue for the 12...